NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Down 37.0% in September

NovAccess Global Inc. (OTCMKTS:XSNX) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,400 shares, a decline of 37.0% from the September 15th total of 5,400 shares. Based on an average daily trading volume, of 73,100 shares, the short-interest ratio is presently 0.0 days.

NovAccess Global Trading Up 8.9 %

OTCMKTS:XSNX opened at $0.01 on Monday. NovAccess Global has a 12 month low of $0.00 and a 12 month high of $0.07. The firm has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.01. The company has a market capitalization of $272,078.30, a P/E ratio of -0.05 and a beta of 1.82.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.